{"id":"W2735778907","doi":"10.1016/s0140-6736(17)31611-2","title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":455,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Parent Project Muscular Dystrophy; National Institute for Health and Care Research; PTC Therapeutics; Muscular Dystrophy Association","keywords":"Medicine; Duchenne muscular dystrophy; Clinical endpoint; Placebo; Nonsense mutation; Internal medicine; Pediatrics; Physical therapy; Subgroup analysis; Clinical trial; Confidence interval; Mutation; Missense mutation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003604752,0.0001891277,0.0004258993,0.00003026287,0.0002334235,0.00005652802,0.0003833169,0.0001218262,0.0000209692],"category_scores_gemma":[0.000228355,0.000118969,0.0001149435,0.00003193503,0.0001550407,0.000012803,0.00006900521,0.0001471768,0.00001284356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000905622,"about_ca_system_score_gemma":0.00005337905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007531075,"about_ca_topic_score_gemma":0.0001516647,"domain_scores_codex":[0.9988662,0.0001663609,0.0002278709,0.0003142192,0.000124173,0.000301163],"domain_scores_gemma":[0.9987072,0.00004166021,0.0002512936,0.00088104,0.00006549586,0.00005332978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9940338,0.00040005,0.001138632,0.00001111076,0.0001860514,0.00000612262,0.00007584175,0.000175092,0.0027349,0.00001213025,0.0003612146,0.0008651083],"study_design_scores_gemma":[0.9922607,0.0008389613,0.004678759,0.00001391718,0.00008912438,9.785734e-7,0.00002323885,0.000143244,0.001034058,0.00003684405,0.0007016287,0.0001785618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964696,0.00008974106,0.00009547206,0.0003661106,0.0001618246,0.002191817,0.00002756231,0.000009761243,0.0005881064],"genre_scores_gemma":[0.9986127,0.00003388105,0.00008603679,0.0001971577,0.0004623455,0.0002373965,0.0002920648,0.00001733815,0.00006108444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003540127,"threshold_uncertainty_score":0.4851415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01846556672422483,"score_gpt":0.2907726574943901,"score_spread":0.2723070907701653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}